|
1
|
Vokes EE, Weichselbaum RR, Lippman SM and
Hong WK: Head and neck cancer. N Engl J Med. 328:184–194. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics. CA Cancer J Clin. 60:277–300. 2010.
|
|
3
|
Gollin SM: Chromosomal alterations in
squamous cell carcinomas of the head and neck: window to the
biology of disease. Head Neck. 23:238–253. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brieger J, Jacob R, Riazimand HS, Essig E,
Heinrich UR, Bittinger F and Mann WJ: Chromosomal aberrations in
premalignant and malignant squamous epithelium. Cancer Genet
Cytogenet. 144:148–155. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ha PK and Califano JA: Promoter
methylation and inactivation of tumour suppressor genes in oral
squamous cell carcinoma. Lancet Oncol. 7:77–82. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esteller M, Corn PG, Baylin SB and Herman
JG: A gene hypermethylation profile of human cancer. Cancer Res.
61:3225–3229. 2001.PubMed/NCBI
|
|
7
|
Brieger J, Pongsapich W, Mann SA, Hedrich
J, Fruth K, Pogozelski B and Mann WJ: Demethylation treatment
restores hic1 expression and impairs aggressiveness of head and
neck squamous cell carcinoma. Oral Oncol. 46:678–683. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hogg RP, Honorio S, Martinez A,
Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ,
Maher ER and Latif F: Frequent 3p allele loss and epigenetic
inactivation of the RASSF1A tumour suppressor gene from region
3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer.
38:1585–1592. 2002. View Article : Google Scholar
|
|
9
|
Viswanathan M, Tsuchida N and Shanmugam G:
Promoter hypermethylation profile of tumor-associated genes p16,
p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
Int J Cancer. 105:41–46. 2003. View Article : Google Scholar
|
|
10
|
Kato K, Hara A, Kuno T, Mori H, Yamashita
T, Toida M and Shibata T: Aberrant promoter hypermethylation of p16
and MGMT genes in oral squamous cell carcinomas and the surrounding
normal mucosa. J Cancer Res Clin Oncol. 132:735–743. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van der Weyden L, Tachibana KK, Gonzalez
MA, Adams DJ, Ng BL, Petty R, Venkitaraman AR, Arends MJ and
Bradley A: The RASSF1A isoform of RASSF1 promotes microtubule
stability and suppresses tumorigenesis. Mol Cell Biol.
25:8356–8367. 2005.PubMed/NCBI
|
|
12
|
Jiricny J and Nyström-Lahti M: Mismatch
repair defects in cancer. Curr Opin Genet Dev. 10:157–161. 2000.
View Article : Google Scholar
|
|
13
|
Pegg AE: Mammalian O6-alkylguanine-DNA
alkyltransferase: regulation and importance in response to
alkylating carcinogenic and therapeutic agents. Cancer Res.
50:6119–6129. 1990.PubMed/NCBI
|
|
14
|
Baylin SB, Esteller M, Rountree MR,
Bachman KE, Schuebel K and Herman JG: Aberrant patterns of DNA
methylation, chromatin formation and gene expression in cancer. Hum
Mol Genet. 10:687–692. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Belinsky SA, Liechty KC, Gentry FD, Wolf
HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, et
al: Promoter hypermethylation of multiple genes in sputum precedes
lung cancer incidence in a high-risk cohort. Cancer Res.
66:3338–3344. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Daskalakis M, Nguyen TT, Nguyen C,
Guldberg P, Kohler G, Wijermans P, Jones PA and Lubbert M:
Demethylation of a hypermethylated P15/INK4B gene in patients with
myelodysplastic syndrome by 5-aza-2′-deoxycytidine (decitabine)
treatment. Blood. 100:2957–2964. 2002.PubMed/NCBI
|
|
17
|
Ruter B, Wijermans PW and Lubbert M: DNA
methylation as a therapeutic target in hematologic disorders:
recent results in older patients with myelodysplasia and acute
myeloid leukaemia. Int J Hematol. 80:128–135. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Welkoborsky HJ, Jacob R, Riazimand SH,
Bernauer HS and Mann WJ: Molecular biologic characteristics of
seven new cell lines of squamous cell carcinomas of the head and
neck and comparison to fresh tumor tissue. Oncology. 65:60–71.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin CJ, Grandis JR, Carey TE, Gollin SM,
Whiteside TL, Koch WM, Ferris RL and Lai SY: Head and neck squamous
cell carcinoma cell lines: established models and rationale for
selection. Head Neck. 29:163–188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nan HM, Song YJ, Yun HY, Park JS and Kim
H: Effects of dietary intake and genetic factors on
hypermethylation of the hMLH1 gene promoter in gastric cancer.
World J Gastroenterol. 11:3834–3841. 2005.PubMed/NCBI
|
|
22
|
Burbee DG, Forgacs E, Zöchbauer-Müller S,
Shivakumar L, Fong K, Gao B, Randle D, Kondo M, Virmani A, Bader S,
et al: Epigenetic inactivation of RASSF1A in lung and breast
cancers and malignant phenotype suppression. J Natl Cancer Inst.
93:691–699. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gosepath J, Brieger J, Lehr HA and Mann
WJ: Expression, localization and significance of vascular
permeability/vascular endothelial growth factor in nasal polyps. Am
J Rhinol. 19:7–13. 2005.PubMed/NCBI
|
|
24
|
Ahmed SA, Gogal RM and Walsh JE: A new
rapid and simple non-radioactive assay to monitor and determine the
proliferation of lymphocytes: an alternative to
[3H]thymidine incorporation assay. J Immunol Methods.
170:211–224. 1994.PubMed/NCBI
|
|
25
|
Liu K, Zuo C, Luo QK, Suen JY, Hanna E and
Fan CY: Promoter hypermethylation and inactivation of hMLH1, a DNA
mismatch repair gene, in head and neck squamous cell carcinoma.
Diagn Mol Pathol. 12:50–56. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Steinmann K, Sandner A, Schagdarsurengin U
and Dammann RH: Frequent promoter hypermethylation of tumor-related
genes in head and neck squamous cell carcinoma. Oncol Rep.
22:1519–1526. 2009.PubMed/NCBI
|
|
27
|
Ogi K, Toyota M, Ohe-Toyota M, Tanaka N,
Noguchi M, Sonoda T, Kohama G and Tokino T: Aberrant methylation of
multiple genes and clinicopathological features in oral squamous
cell carcinoma. Clin Cancer Res. 8:3164–3171. 2002.PubMed/NCBI
|
|
28
|
Wang Y, Irish J, MacMillan C, Brown D,
Xuan Y, Boyington C, Gullane P and Kamel-Reid S: High frequency of
microsatellite instability in young patients with head-and-neck
squamous-cell carcinoma: lack of involvement of the mismatch repair
genes hMLH1 and hMSH2. Int J Cancer. 93:353–360. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wright CL and Stewart ID: Histopathology
and mismatch repair status of 458 consecutive colorectal
carcinomas. Am J Surg Pathol. 27:1393–1406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto M, Taguchi K, Baba H, Endo K,
Kohnoe S, Okamura T and Maehara Y: Loss of protein expression of
hMLH1 and hMSH2 with double primary carcinomas of the stomach and
colorectum. Oncol Rep. 16:41–47. 2006.PubMed/NCBI
|
|
31
|
Czerninski R, Krichevsky S, Ashhab Y,
Gazit D, Patel V and Ben-Yehuda D: Promoter hypermethylation of
mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell
carcinoma. Oral Dis. 15:206–213. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dong SM, Sun DI, Benoit NE, Kuzmin I,
Lerman MI and Sidransky D: Epigenetic inactivation of RASSF1A in
head and neck cancer. Clin Cancer Res. 9:3635–3640. 2003.PubMed/NCBI
|
|
33
|
Lo KW, Kwong J, Hui AB, Chan SY, To KF,
Chan AS, Chow LS, Teo PM, Johnson PJ and Huang DP: High frequency
of promoter hypermethylation of RASSF1A in nasopharyngeal
carcinoma. Cancer Res. 61:3877–3881. 2001.PubMed/NCBI
|
|
34
|
Zuo C, Ai L, Ratliff P, Suen JY, Hanna E,
Brent TP and Fan CY: O6-methylguanine-DNA methyltransferase gene:
epigenetic silencing and prognostic value in head and neck squamous
cell carcinoma. Cancer Epidemiol Biomarkers Prev. 13:967–975.
2004.PubMed/NCBI
|
|
35
|
Paluszczak J, Misiak P, Wierzbicka M,
WoŸniak A and Baer-Dubowska W: Frequent hypermethylation of DAPK,
RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell
carcinomas and adjacent normal mucosa. Oral Oncol. 47:104–107.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Esteller M, Gaidano G, Goodman SN, Zagonel
V, Capello D, Botto B, Rossi D, Gloghini A, Vitolo U, Carbone A, et
al: Hypermethylation of the DNA repair gene O(6)-methylguanine DNA
methyltransferase and survival of patients with diffuse large
B-cell lymphoma. J Natl Cancer Inst. 94:26–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Esteller M, Garcia-Foncillas J, Andion E,
Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB and Herman JG:
Inactivation of the DNA-repair gene MGMT and the clinical response
of gliomas to alkylating agents. N Engl J Med. 343:1350–1354. 2000.
View Article : Google Scholar
|
|
38
|
Park TJ, Han SU, Cho YK, Paik WK, Kim YB
and Lim IK: Methylation of O(6)-methylguanine-DNA methyltransferase
gene is associated significantly with K-ras mutation, lymph node
invasion, tumor staging, and disease free survival in patients with
gastric carcinoma. Cancer. 92:2760–2768. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cameron EE, Bachman KE, Myöhänen S, Herman
JG and Baylin SB: Synergy of demethylation and histone deacetylase
inhibition in the re-expression of genes silenced in cancer. Nat
Genet. 21:103–107. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shen WJ, Dai DQ, Teng Y and Liu HB:
Regulation of demethylation and re-expression of RASSF1A gene in
gastric cancer cell lines by combined treatment of 5-Aza-CdR and
NaB. World J Gastroenterol. 14:595–600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Costello JF, Frühwald MC, Smiraglia DJ,
Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomäki P,
Lang JC, et al: Aberrant CpG-island methylation has non-random and
tumour-type-specific patterns. Nat Genet. 24:132–138. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Karpf AR and Jones DA: Reactivating the
expression of methylation silenced genes in human cancer. Oncogene.
21:5496–5503. 2002. View Article : Google Scholar : PubMed/NCBI
|
